Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" or "effective." A pressing question for many users of GLP-1 receptor agonist ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...

The changes coming with the new year — including a lower cap on out-of-pocket prescription-drug costs and a new program designed to help enrollees spread out their medication costs over the ...

Medicare's prescription drug coverage will change in 2025. There will be a $2000 cap on out-of-pocket expenses for ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

This is because cats use more energy to break whole carbs down, says Dr. Korinn Saker, associate professor of clinical nutrition at the College of Veterinary Medicine at North Carolina State ...

I’m not a perfect role model for a healthy or sustainable diet. I know I should eat more fruits and veggies and less red meat. Once, a climate team colleague reporting on the massive greenhouse ...

including approval of a pathway for prescription drugs to be imported from Canada as well as the voluntary $35 insulin Medicare copayment cap. But she did not offer new insulin-specific ...

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

Zepbound (tirzepatide) is an injectable drug for weight loss in those with obesity or those with overweight and a weight-related condition. It is available by prescription in person and online.